Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema

PURPOSE: Pegaptanib has been shown to be effective in treating diabetic macular edema (DME). In the original Phase II/III trial, however, patients with macular ischemia were excluded. In this study, we treated patients with ischemic DME. METHODS: Macular ischemia was defined as a 30% increase in the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Ophthalmol
Asıl Yazarlar: Kiire, Christine A, Morjaria, Rupal, Rudenko, Anna, Fantato, Alexina, Smith, Lewis, Smith, Amy, Chong, Victor
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4686329/
https://ncbi.nlm.nih.gov/pubmed/26715833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S90322
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller